TM30339: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel, Repeated Subcutaneous Dose-Range Study Designed to Determine the Weight Loss in Obese Subjects
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2012
At a glance
- Drugs TM 30339 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 31 Aug 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2008 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.